Form 8-K - Current report:
SEC Accession No. 0001193125-17-263720
Filing Date
2017-08-21
Accepted
2017-08-21 16:45:33
Documents
4
Period of Report
2017-08-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d639616d8k.htm 8-K 22111
2 EX-5.1 d639616dex51.htm EX-5.1 9422
3 EX-10.1 d639616dex101.htm EX-10.1 17254
4 GRAPHIC g639616g0819071515241.jpg GRAPHIC 2525
  Complete submission text file 0001193125-17-263720.txt   53787
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 171043473
SIC: 2835 In Vitro & In Vivo Diagnostic Substances